Vendors & EquipmentHuaweiQualcommPatent Licensing5g

Huawei, Qualcomm sign multi-year patent licence spanning 5G, AI and compute

Huawei and Qualcomm signed a multi-year cross-licence on 5 October 2026 spanning 5G, compute, AI and networking, with Qualcomm separately acquiring certain Huawei US patents pending regulatory approval.

3 min read

Huawei, Qualcomm agree to broad patent license dealVendors & Equipment
Huawei, Qualcomm agree to broad patent license dealAI-generated

Why it matters

  • Huawei and Qualcomm announced a multi-year, broad patent cross-licence on 5 October 2026 covering 5G, compute, AI and networking
  • Qualcomm will separately acquire certain Huawei US patents in compute, AI, networking and adjacent technologies, subject to regulatory approval
  • Both companies framed the agreement under fair, reasonable and non-discriminatory (FRAND) principles
  • The financial value of the cross-licence, its duration, and the number of patents covered were not disclosed
  • The patent purchase will close following receipt of the necessary regulatory approvals

The story

Huawei and Qualcomm announced a multi-year, broad patent licence agreement on 5 October 2026 covering cross-licences to their respective patent portfolios across 5G, compute, AI and networking. The deal also includes Qualcomm's purchase of certain Huawei US patents in the same technology areas, a transaction the companies said will close once it receives the necessary regulatory approvals.

The two companies framed the agreement as a reaffirmation of their commitment to intellectual property rights and to licensing practices consistent with fair, reasonable and non-discriminatory (FRAND) principles, the framework that underpins standards-essential patent (SEP) licensing in the telecoms industry.

What the deal covers

The cross-licence spans four technology fields: 5G, compute, AI and networking. Huawei and Qualcomm are both significant contributors of declared SEPs to the 3GPP specifications that define 5G New Radio, the 5G core and adjacent systems, which makes the breadth of the agreement notable for the wider patent ecosystem.

The agreement is multi-year, but neither company disclosed its duration, the financial value of the cross-licence, or the size of the patent portfolio being transferred to Qualcomm in the United States.

Why the US patent purchase matters separately

Beyond the cross-licence, Qualcomm's acquisition of certain Huawei US patents introduces a second commercial mechanism. Patents sold into the United States by a Chinese counterparty typically require review under national-security screening frameworks, although the announcement did not name the specific approval pathway.

The transaction's structure suggests Qualcomm is buying patents that complement its existing compute, AI and networking portfolios, rather than replacing cross-licence royalties. Deal terms remain undisclosed, leaving the effective transfer price and the exact patent counts out of public view.

Where the FRAND framework fits

By invoking FRAND explicitly, both parties are positioning the agreement within the standards-licensing framework that ETSI, 3GPP and most major jurisdictions require for SEPs. The joint statement reads: "The agreement reflects the companies' shared commitment to intellectual property rights and to licensing practices consistent with fair, reasonable and non-discriminatory (FRAND) principles."

This language matters because SEP disputes have produced several high-profile rulings in recent years in the United Kingdom, China, India and the European Union. A pre-emptive, broad cross-licence removes one potential flashpoint between two of the industry's most active patent holders.

What is not in the announcement

The press release did not name either company's chief executive as a signatory, did not specify the number of patents covered, and did not disclose the financial value of the cross-licence or the patent purchase. The announcement also did not indicate whether the agreement changes the licensing terms Huawei and Qualcomm extend to downstream equipment vendors and handset makers.

What to watch next

The closing of the US patent transaction now depends on regulatory clearance. The cross-licence itself, by contrast, takes effect on signing and will run for the multi-year term agreed. Observers will look for subsequent filings with the US Patent and Trademark Office and any disclosure of portfolio size once the deal closes, with the regulatory review timeline the most concrete near-term milestone.

Also reported

Original: qualcomm.com

Share this article:

« PreviousNext »

More from Amara Osei

Amara Osei

Show full bio

News editor covering media and advertising at Telecom Gazette.

154 articles